- Investing Ideas
- /
- Swiss High Growth Potential Companies
Swiss High Growth Potential Companies
UPDATED Apr 22, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
96 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NWRN | CHF7.18 | -0.6% | 59.6% | CHF133.8m | CHF13.01 | PS15.2x | E53.3% | n/a | Pharmaceuticals & Biotech | ||
MBTN | CHF0.01 | 2.0% | -98.3% | CHF242.0m | n/a | PS1.8x | E86.7% | n/a | Semiconductors | ||
AMS | CHF0.93 | -4.1% | -84.1% | CHF916.5m | CHF3.37 | PB0.5x | E100.4% | 0% | Semiconductors | ||
STMN | CHF135.10 | -0.7% | -0.7% | CHF21.5b | CHF141.56 | PE87.5x | E23.6% | 0.6% | Healthcare | ||
COTN | CHF280.00 | -6.8% | 35.1% | CHF2.2b | CHF329.40 | PE141.4x | E41.5% | 0.4% | Tech | ||
RSGN | CHF10.75 | 0.5% | 12.6% | CHF300.2m | CHF12.15 | PE25.8x | E25.3% | 2.3% | Capital Goods | ||
DAE | CHF168.80 | 0.1% | -17.7% | CHF2.9b | CHF182.67 | PE43x | E22.1% | 1.9% | Capital Goods | ||
INA | CHF18.45 | 2.8% | 2.8% | CHF305.4m | CHF17.20 | PS15.1x | E39.8% | n/a | Real Estate Management and Development | ||
VACN | CHF449.30 | -6.7% | 46.7% | CHF13.5b | CHF456.31 | PE70.8x | E21.2% | 1.4% | Capital Goods | ||
SWON | CHF16.10 | -1.6% | 20.4% | CHF2.5b | CHF17.62 | PE115.9x | E33.6% | 2.2% | Tech | ||
BSLN | CHF40.90 | -0.5% | -6.6% | CHF490.9m | CHF70.58 | PE47x | E32.4% | 0% | Pharmaceuticals & Biotech | ||
COPN | CHF73.40 | 4.1% | 34.2% | CHF1.2b | CHF93.67 | PE1056.9x | E30.4% | 2.6% | Pharmaceuticals & Biotech | ||
ARBN | CHF12.16 | 5.0% | 14.7% | CHF843.3m | CHF11.08 | PE59.3x | E37.4% | 0% | Capital Goods | ||
MOVE | CHF110.00 | -4.3% | -2.8% | CHF2.2b | CHF142.95 | PE47.6x | E21.8% | 0.5% | Healthcare | ||
DOCM | CHF82.80 | -9.0% | 118.5% | CHF973.9m | CHF99.24 | PS1x | E67.3% | 0% | Consumer Retailing | ||
SRAIL | CHF27.35 | -0.7% | -25.9% | CHF2.7b | CHF30.62 | PE22x | E23.4% | 3.3% | Capital Goods | ||
LEHN | CHF1,560.00 | -0.8% | -22.0% | CHF1.8b | CHF2,113.25 | PE23.5x | E9.9% | 3.3% | Tech | ||
SKAN | CHF77.90 | -5.7% | -10.7% | CHF1.8b | CHF91.33 | PE66.6x | E34.8% | 0.4% | Pharmaceuticals & Biotech | ||
SHLTN | CHF4.60 | -8.0% | -48.9% | CHF75.4m | n/a | PS1.4x | E96.2% | 0% | Healthcare | ||
SDZ | CHF31.02 | 11.1% | n/a | CHF13.3b | CHF35.13 | PE189.8x | E29.7% | 1.4% | Pharmaceuticals & Biotech | ||
MCHN | CHF5.26 | 4.0% | 13.1% | CHF162.4m | CHF7.00 | PB1.7x | E101.5% | 0% | Media | ||
BCHN | CHF581.00 | -1.2% | 6.2% | CHF2.0b | CHF604.50 | PE25.3x | E12.8% | 2.1% | Capital Goods | ||
DOKA | CHF468.00 | -2.3% | 19.7% | CHF2.0b | CHF478.00 | PE46.3x | E47.3% | 2.0% | Capital Goods | ||
SQN | CHF245.00 | -0.6% | 26.9% | CHF3.6b | CHF247.00 | PE16.7x | E14.3% | 1.8% | Diversified Financials |